Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …

In early December 2019, a large pneumonia epidemic occurred in Wuhan, China. The World
Health Organization is concerned about the outbreak of another coronavirus with the …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a more severe strain of
coronavirus (CoV) that was first emerged in China in 2019. Available antiviral drugs could …

COVID-19 is a pulmonary disease caused by SARS-CoV-2. More than 200 million
individuals are infected by this globally. Pyrexia, coughing, shortness of breath, headaches …

Recent studies have revealed considerable promise in the antiviral properties of metal
nanomaterials, specifically when biologically prepared. This study demonstrates for the first …

Nucleosides and their derivatives are a well-known and well-described class of compounds
with antiviral activity. Currently, in the era of the COVID-19 pandemic, scientists are also …

Objective Many studies have suggested herbal medicines as alternatives or adjuvants to
modern drugs for COVID-19. Their scientometric analyses can provide a scientific overview …

Covid-19 is a respiratory disease caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) that spreads by person-to-person contact. The virus is thought …

Background: Most systems of traditional medicine have been using herbal medicines to
prevent and treat acute respiratory conditions and various other conditions for centuries. The …

In the pandemic era of COVID-19, there is an urgent need to develop a safe and effective
vaccine to prevent different variants/strains of COVID-19. The developed vaccine must have …